Kaynak: Zacks Investment Research
Haber Ajansı
Hisse Senedi
Orta Önem

BAYRY Beats on Q2 Earnings, Crop Science Business Boosts Growth
Bayer tops Q2 estimates as Crop Science and fast-growing drugs offset pressure from patent-expired brands, while reaffirming its 2026 outlook.
İlgili Semboller
1
B
BAYRY
BAYRY
Kaynak: Zacks Investment Research
Kaynağı Ziyaret Et